Vivo Capital, LLC Novavax Inc Transaction History

Vivo Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$177.8 - $270.58 $15.7 Million - $23.8 Million	-88,046 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$121.0 - $257.67 $8.4 Million - $17.9 Million	-69,441 Reduced 44.09%	88,046 $18.7 Million
Q4 2020 Feb 16, 2021	SELL	$78.74 - $139.5 $528,502 - $936,324	-6,712 Reduced 4.09%	157,487 $17.6 Million
Q3 2020 Nov 13, 2020	BUY	$79.44 - $178.51 $13 Million - $29.3 Million	164,199 New	164,199 $17.8 Million

286

84.8M

5.43M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $713M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Vivo Capital, LLC with notifications on news.